Synergistic Cardiac Ablation Systems
Legal Citation
Summary of the Inventive Concept
The present invention integrates a semi-circular ablation catheter with distinct technologies, such as AI, IoT, blockchain, and novel nanomaterials, to create a more powerful and efficient cardiac ablation system.
Background and Problem Solved
The original semi-circular ablation catheter, while effective, has limitations in terms of navigation, data management, and treatment optimization. The present invention addresses these limitations by combining the catheter with advanced technologies to enhance treatment outcomes and patient care.
Detailed Description of the Inventive Concept
The synergistic cardiac ablation system comprises a semi-circular ablation catheter integrated with an AI-powered navigation module, an IoT-enabled patient monitoring system, a blockchain-based data storage module, and a novel nanomaterial-based electrode. The AI-powered navigation module optimizes treatment patterns, while the IoT-enabled patient monitoring system provides real-time patient data. The blockchain-based data storage module ensures secure and transparent data management. The novel nanomaterial-based electrode enhances ablation efficiency. The system utilizes machine learning algorithms to analyze patient data and predict optimal treatment outcomes.
Novelty and Inventive Step
The integration of the semi-circular ablation catheter with AI, IoT, blockchain, and novel nanomaterials is new and non-obvious, as it combines distinct technologies to create a more powerful and efficient cardiac ablation system. The use of machine learning algorithms to analyze patient data and predict optimal treatment outcomes is also novel and inventive.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include integrating the semi-circular ablation catheter with robotic-assisted navigation systems, machine learning-based patient profiling modules, or AI-powered treatment planning modules. Variations could also include using different types of advanced materials or technologies to enhance ablation efficiency and treatment outcomes.
Potential Commercial Applications and Market
The synergistic cardiac ablation system has significant commercial potential in the medical device industry, particularly in the areas of cardiac arrhythmia treatment and patient care. The system's ability to enhance treatment outcomes, reduce procedure time, and provide secure and transparent data management makes it an attractive solution for hospitals, clinics, and medical professionals.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61B18/1492 |
| A | A61 | A61B2017/003 |
| A | A61 | A61B2018/00351 |
| A | A61 | A61B2018/00357 |
| A | A61 | A61B2018/00375 |
| A | A61 | A61B2018/00577 |
| A | A61 | A61B2018/00642 |
| A | A61 | A61B2018/00702 |
| A | A61 | A61B2018/00726 |
| A | A61 | A61B2018/00821 |
| A | A61 | A61B2018/1407 |
| A | A61 | A61B2018/1467 |
| A | A61 | A61B2018/1807 |
Original Patent Information
| Patent Number | US 11,857,250 |
|---|---|
| Title | Semi-circular ablation catheter |
| Assignee(s) | Medtronic Ablation Frontiers LLC |